The last trading day is November 8.
Onxeo soon to be delisted from the Nasdaq | Photo credit: Shutterstock
As announced on August 17, 2022, Onxeo will soon no longer be listed on the Nasdaq Composite. The last joint general meeting of the biotech has indeed approved the withdrawal of the shares and their delisting from trading on the Nasdaq First North Growth market. The last trading day is November 8.
The action remains on a last course of 34 cents.
Invest